Cargando…
Non-commercial pharmaceutical R&D: what do neglected diseases suggest about costs and efficiency?
Background: The past two decades have witnessed significant growth in non-commercial research and development (R&D) initiatives, particularly for neglected diseases, but there is limited understanding of the ways in which they compare with commercial R&D. This study analyses costs, timelines...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063537/ https://www.ncbi.nlm.nih.gov/pubmed/33953909 http://dx.doi.org/10.12688/f1000research.28281.2 |